Facing a small cell lung cancer (SCLC) diagnosis can be overwhelming. Beyond the medical complexities, one of the biggest challenges can be knowing what to ask about diagnosis, treatment options, or how the disease may affect daily life.
To empower patients during conversations with their care team, we offer digital resources designed to help those affected by SCLC take an active role in their care. Two key tools, the Doctor Discussion Guide and Maintenance Therapy Fact Sheet, offer information and prompts to support meaningful conversations with healthcare teams.
Every individual’s experience with SCLC is unique. Conversations with your doctor will vary depending on your treatment journey, overall health, and response to initial therapy, also called induction therapy.
The Doctor Discussion Guide helps patients and caregivers feel prepared and confident when meeting with their healthcare team. It offers practical tips for appointments, suggested questions to explore diagnosis and treatment options, and guidance for discussing maintenance therapy, which may help extend the benefits of initial treatment.
By using this guide, patients can move from simply listening to actively shaping their care plan.
For many patients who have completed induction therapy, the next question is what comes after. Maintenance therapy may be one option.
The Maintenance Therapy Fact Sheet builds on that conversation, providing clear, easy-to-understand information about the role of maintenance therapy in SCLC and what patients might expect when discussing this approach with their doctor.
Together, these resources are designed to help patients and caregivers feel informed, confident and supported as they navigate next steps in care.
Navigating an SCLC diagnosis can feel isolating, but patients and caregivers do not have to face it alone. Accessing credible information and support can help foster understanding and connection throughout the care journey.
Continuing to learn about SCLC, even outside of the doctor’s office, can help patients become more informed and engaged in their care. Whether you are a patient or a caregiver, exploring trusted resources and conversation tools can help you approach an SCLC diagnosis with greater understanding, confidence and a sense of connection.
Learn more about the importance of first-line maintenance therapy in small cell lung cancer.
الإبلاغ عن أثر جانبي
إذا كنت ترغب في الإبلاغ عن أثر جانبي مرتبط بالمنتجات الدوائية لشركة Jazz Pharmaceuticals، يُرجى إرسال بريد إلكتروني إلينا عبر الرابط التالي:
يُرجى تقديم أكبر قدر ممكن من المعلومات المتاحة.
تشمل المعلومات ذات الصلة ما يلي:
بتقديمك لتقريرك وتزويدنا ببيانات الاتصال الخاصة بك، فإنك تُقرّ وتوافق صراحةً على أنه يجوز لقسم السلامة الدوائية المحلي التواصل معك بغرض طلب معلومات إضافية أو توضيحات، إذا اعتُبر ذلك ضروريًا لتقييم التقرير ومتابعته.
يوضح إشعار الخصوصية الخاص بنا المتعلق باليقظة الدوائية والمعلومات الطبية وشكاوى المنتجات كيفية تعامل شركة Jazz Pharmaceuticals مع معالجة المعلومات الشخصية عند التعامل مع تقريرالأثر الجانبي الخاص بك، وهو متاح في مركز الخصوصية لدينا.
Report an Adverse Event
If you want to report a Adverse Event related to Jazz Pharmaceuticals medicinal products, then please send us an e-mail via this link:
Please provide as much available information as possible.
Relevant information includes:
By submitting your report and providing your contact details, you expressly acknowledge and agree that the local drug safety department may contact you for the purpose of requesting additional information or clarifications, should this be deemed necessary for the assessment and follow‑up of the report.
Our Privacy Notice for Pharmacovigilance, Medical Information and Product Complaints outlines how Jazz Pharmaceuticals handles the processing of personal information when dealing with your adverse event report and is available in our Privacy Center.
